oral drugs
| 5 min read
Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.
| 3 min read
How a team at Pfizer turned a decade-old compound into the fastest small molecule drug for COVID-19.
| 2 min read
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model.
| 3 min read
COPD breakthroughs, billion-dollar biotech bets, brain-computer trials, and a historic push for women’s health led the news this week.
| 5 min read
A groundbreaking approach targets muscle stem cells to restore regeneration in Duchenne muscular dystrophy, offering new hope beyond traditional dystrophin-focused therapies.
Page 1 of 1 - 5 Total Items
